Stockreport

Eyenovia Congratulates Formosa Pharmaceuticals on FDA Approval of Clobetasol Propionate Ophthalmic Suspension 0.05% for the Treatment of Post-operative Inflammation and Pain Following Ocul...

Eyenovia, Inc.  (EYEN) 
Last eyenovia, inc. earnings: 3/25 04:05 pm Check Earnings Report
PDF Eyenovia plans to launch in the U.S. as soon as this summer using its Mydcombi™ sales force providing pre-surgical pupil dilation and post-surgical care in an estimated [Read more]